Radisys Expands Access Portfolio with the Launch of Connect Open Broadband
21.5.2020 10:22:00 EEST | Business Wire | Press release
Radisys® Corporation, a global leader of open telecom solutions, today introduced Connect Open Broadband, a carrier-grade, Tier 1 network-hardened, scalable and secure software-defined Passive Optical Network (PON) distribution based on open standards and web-scale architecture to drive rapid innovation and economies of scale. The disaggregated PON solution gives Communications Service Providers (CSPs) deployment flexibility, scalable network growth, and increased service agility with optimized CapEx and OpEx.
News Highlights
- The demand for high-speed broadband services such as internet, video calling and conferencing, and IPTV has created massive growth in network data usage like never before. As such, CSPs’ networks are increasingly overburdened. Service providers need to optimize their networks to scale service delivery efficiently, while maximizing the opportunity to deliver innovation at a rapid pace.
- Radisys’ Connect Open Broadband offers an intelligent, scalable and secure software-defined PON distribution based on the Open Networking Foundation’s (ONF) SEBA reference platform and enhanced with Radisys innovation. This architecture allows for a seamless introduction of the Broadband Forum’s OB-BAA architecture by conforming to the standard YANG models with the Northbound Interface (NBI).
- The solution disaggregates software from the underlying hardware with open interfaces, enabling faster product innovation cycles. The hardware agnostic solution enables service providers to leverage white-box optical line terminals (OLTs) from an interoperable multi-vendor ecosystem for flexible deployable options.
- Connect Open Broadband, built on cloud-native microservices architecture, allows for the addition of new network functions on demand and delivers a path to automated and simplified network operation. The programmability, automation and deeper network visibility further enables better fault detection, faster service delivery and future-proof network expansions.
- The solution is access network (GPON, XGS-PON, NG-PON2) agnostic and offers flexible deployment options.
“In the digital era where high-bandwidth services and pervasive connectivity are required to meet subscriber expectations, service providers are rethinking how they build their networks to meet demand with optimal performance and value,” said Harris Razak, senior vice president of Broadband Access, Radisys. “Connect Open Broadband is a commercially ready, network-hardened solution that allows service providers to enable rapid innovation through disaggregation and to bring new services to market faster.”
“Radisys has been a Partner Member of ONF for many years and has been one of the most active supply chain members working directly with our operator partners. Radisys has helped drive ONF open reference designs and open source platforms and is among the first to commercialize solutions based on ONF platforms,” said Guru Parulkar, Executive Director, ONF. “Radisys’ Connect Open Broadband combines open architectures, software innovation, and white-box hardware to facilitate service agility.”
“Broadband service providers face increased pressure to deliver innovative services to compete with OTT providers,” said Simon Stanley, Analyst at Large, Heavy Reading. “Open, disaggregated solutions give service providers the flexibility to select best-in-class network elements from a number of vendors in order to intelligently scale their networks and deliver the services their customers demand in a cost-effective manner.”
Resources:
- Solution Brief: Connect Open Broadband Access
- Heavy Reading Webinar: Supercharge Your Fiber Broadband Service, May 21 at 12 pm ET
About Radisys
Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio from digital end points, to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com.
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200519005223/en/
Contact information
Nereus for Radisys
Lori Mesecke, +1-503-459-9150
lmesecke@nereus-worldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
